v3.26.1
Stock Options (Details)
6 Months Ended
Feb. 28, 2026
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares subject to option grants, outstanding | shares 5,206,000
Weighted average exercise price, outstanding balance | $ / shares $ 2.37
Weighted average remaining contractual term (years), outstanding 3 years 14 days
Number of shares subject to option grants, exercisable | shares 5,206,000
Weighted average exercise price, exercisable | $ / shares $ 2.37
Equity Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares subject to option grants, outstanding | shares 5,206,000
Weighted average exercise price, outstanding balance | $ / shares $ 2.37
Weighted average remaining contractual term (years), outstanding 3 years 14 days
Aggregate intrinsic value, outstanding | $ $ 37,500
Number of shares subject to option grants, exercisable | shares 5,206,000
Weighted average exercise price, exercisable | $ / shares $ 2.37
Weighted average remaining contractual term (years), exercisable 3 years 14 days
Aggregate intrinsic value, Exercisable | $ $ 37,500